Two deaths after Novartis' Zolgensma put gene therapy’s liver safety in the spotlight once again
12th August 2022 Uncategorised 0 Two deaths after Novartis’ Zolgensma put gene therapy’s liver safety in the spotlight once again
aliu
Fri, 08/12/2022 – 10:54
More: Two deaths after Novartis' Zolgensma put gene therapy’s liver safety in the spotlight once again
Source: fierce